Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Amdocs Limited (NASDAQ:DOX – Free Report) during the third quarter, HoldingsChannel reports. The firm bought 1,493 shares of the technology company’s stock, valued at approximately $131,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Private Trust Co. NA lifted its stake in Amdocs by 62.9% in the third quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock valued at $27,000 after acquiring an additional 117 shares during the last quarter. Brooklyn Investment Group acquired a new stake in Amdocs in the 3rd quarter valued at about $28,000. Catalyst Capital Advisors LLC bought a new position in Amdocs during the third quarter worth about $55,000. GAMMA Investing LLC increased its position in Amdocs by 115.1% during the third quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock worth $70,000 after buying an additional 428 shares during the last quarter. Finally, American National Bank bought a new stake in Amdocs in the second quarter valued at approximately $76,000. Institutional investors own 92.02% of the company’s stock.
Amdocs Stock Performance
Shares of NASDAQ DOX opened at $87.69 on Tuesday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.20 and a quick ratio of 1.24. The firm has a market cap of $10.31 billion, a price-to-earnings ratio of 20.68, a P/E/G ratio of 1.45 and a beta of 0.74. The stock’s fifty day moving average price is $88.11 and its two-hundred day moving average price is $84.14. Amdocs Limited has a one year low of $74.41 and a one year high of $94.04.
Amdocs Dividend Announcement
Analysts Set New Price Targets
A number of research firms recently weighed in on DOX. Stifel Nicolaus initiated coverage on Amdocs in a report on Wednesday, October 2nd. They set a “buy” rating and a $100.00 target price on the stock. Barclays reduced their price objective on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research report on Thursday, November 14th. Oppenheimer increased their price objective on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Finally, StockNews.com downgraded shares of Amdocs from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 14th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.20.
Get Our Latest Report on Amdocs
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories
- Five stocks we like better than Amdocs
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- How to Master Trading Discipline: Overcome Emotional Challenges
- Upcoming IPO Stock Lockup Period, Explained
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.